555 POSTER The PARP inhibitor, ABT-888 overcomes resistance in temozolomide refractory breast and prostate xenograft tumors implanted in metastatic sites in vivo
J. Palma, L. Rodriguez, Y.W. Wang, G. Bukofzer, J. Hickson, T. Penning, V. Giranda, S. Rosenberg, D. Frost, C. DonawhoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72489-3
File:
PDF, 59 KB
english, 2008